The central bank is not normally in the business of easing into an economy that is showing few signs of a recession, generally holding fire until more pronounced signs of a...The Fedread more
His case for gold comes as central banks get more aggressive with policies that devalue currencies and are about to cause a "paradigm shift" in investing.Marketsread more
CSX said it expects revenue to fall as much as 2% in 2019, well below a previous forecast of an increase of 1% to 2%.Marketsread more
Challenging conditions in the U.S. housing market, along with tighter currency controls by the Chinese government, cause a stunning drop in foreign demand for American homes.Real Estateread more
The growth in net interest income, a main engine of the industry's profit, looks to slow to a halt in the back half of this year.Banksread more
Here's how Amazon sells ads, and why it has a natural edge over Google and Facebook in some areas.Technologyread more
Netflix reports earnings Wednesday as it loses licensed shows to rivals launching their own streaming services.Technologyread more
Federal Judge William Pauley wrote in a court filing made public Wednesday that materials related to Cohen's campaign-finance probe should be unsealed — and denied a request...Politicsread more
The "'Cadillac tax," set to go into effect in 2022, is unpopular with both Republicans and Democrats, who say it punishes the middle class.Health and Scienceread more
Facebook's head of Calibra David Marcus is grilled during a House Financial Services Committee hearing over the company's digital currency plans.Technologyread more
Gov. Phil Murphy of New Jersey announced a lawsuit against the IRS and Treasury Secretary Steven Mnuchin, responding to new, final rules from the IRS that would largely block...Personal Financeread more
Walgreens Boots Alliance announced plans on Thursday to its cut annual costs by $1 billion within three years and reported first-quarter results that beat Wall Street's estimates.
The results also showed sales are struggling in Britain, one of its largest markets, and the stock dropped 3 percent Thursday morning.
Walgreens shares are down more than 2 percent this year bringing its market value to $69.3 billion. The stock has been under pressure as investors worry about the impact Amazon will have as it expands into the pharmacy business. To prepare for increased competition, Walgreens has announced partnerships with Kroger, Alphabet's Verily and others.
Investors should expect that transforming the traditional drug store business model will take years, CEO Stefano Pessina said.
"Whether it be three or five [years], it is difficult to say because of these [initiatives] take a lot of time to come to real fruition," Pessina said on a conference call with analysts.
Here's what the company reported compared with what Wall Street was expecting, based on a survey of analysts by Refinitiv:
Walgreens Boots Alliance also announced a plan to reduce annual costs by more than $1 billion by the end of its third year. Targets will include global spending, organization and digitalization of the business. The initial focus will be on the U.S. and U.K., the company's largest markets.
The company did not disclose the expected cost of these efforts, but said it had already invested $30 million during its fiscal first quarter.
One-time costs for some improvements to its pharmaceutical wholesale division are expected to be between $150 million and $170 million. This part of the program is expected to save the company between $65 million and $75 million per year.
Revenue during the quarter ended Nov. 30 rose 9.9 percent to $33.79 billion, from $30.7 billion last year. The company's Rite Aid division accounts for some of that sales growth.
However, the company struggled in the U.K. International retail pharmacy sales decreased by 5.9 percent from a year earlier. It blamed a weak retail environment in the U.K. for the decline, despite improving Boots' market share in the country. Pharmacy sales at Boots open at least a year saw sales drop by 3.5 percent during the quarter from a year earlier, while same-store sales for all other retail fell by 2.6 percent.
The company also said that payment changes from the National Health Service and the sale of Boots Contract Manufacturing affected those sales numbers.
The company expects that its cost management program will help its U.K. business. Additionally, it is planning to roll out new beauty brands and products in its Boots stores.
The parent company reported fiscal first-quarter net income of $1.1 billion, or $1.18 per share, up 37 percent from $821 million, or 81 cents a share during the same quarter last year.
Analysts expected the company to generate $33.78 billion in revenue and adjusted earnings of $1.43 a share. On an adjusted basis, the company earned $1.46 a share.
Walgreens also reaffirmed its forecast of growing earnings per share by 7 to 12 percent during the 2019 fiscal year.
CORRECTION: One-time costs for improvements to Walgreens' pharmaceutical wholesale division are expected to be between $150 million and $170 million.